Josefin Beate Holz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Josefin beate holz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Josefin Beate Holz Today - Breaking & Trending Today

STORM Therapeutics to Present Interim Phase 1 Clinical Data on its METTL3 RNA Methyltransferase Inhibitor STC-15 at ASCO 2024

STC-15 is the first METTL3 inhibitor to enter clinical development Clinical data will include safety, pharmacology, target modulation, and clinical activity CAMBRIDGE, England, May ....

United States , San Antonio , United Kingdom , Justin Moser , Jordi Rodon Ahnert , Kyriakos Papadopoulos , Josefin Beate Holz , Honorhealth Research Institute , American Society Of Clinical Oncology , Therapeutics Ltd , Storm Therapeutics Ltd , Ip Group , Utokyo Innovation Platform Co Ltd , Fast Track Initiative , Justin Moser At Honorhealth Research Institute , Seroba Life Sciences , Cambridge Innovation Capital , University Of Texas Md Anderson Cancer Center , Taiho Ventures , American Society , Clinical Oncology , Annual Meeting , Cohort Expansion Study Evaluating Safety , Clinical Activity , Advanced Malignancies , Honorhealth Research ,

STORM Therapeutics publishes data in Cancer Discovery showing induction of anti-tumour immunity by METTL3 inhibition

/PRNewswire/ STORM Therapeutics Ltd. (STORM), a clinical stage biotechnology company focused on discovering and developing novel small molecule therapies. ....

United Kingdom , Oliver Rausch , Mark Dawson , Jerry Mcmahon , Andrewa Guirguis , Peter Mac , Josefin Beate Holz , Peter Maccallum Cancer Centre , Therapeutics Ltd , Utokyo Innovation Platform Co Ltd , Taiho Ventures , Cambridge Innovation Capital , Fast Track Initiative , Ip Group , Seroba Life Sciences , Professor Mark Dawson , Chief Scientific Officer , Beate Holz , Chief Medical Officer , Chief Executive Officer , Yaara Ofir Rosenfeld , Cancer Discovery , Pfizer Ventures , Cambridge Innovation Capitali Limited , Maccallum Cancer Centre , Storm Therapeutics ,

First patient dosed with novel RNA modifying enzyme inhibitor

A Phase I trial for solid tumours has begun to assess STC-15, the first RNA methyltransferase modifying enzyme inhibitor. ....

United Kingdom , Tony Kouzarides , Jerry Mcmahon , Josefin Beate Holz , University Of Cambridge , Milner Therapeutics Institute , Storm Therapeutics ,

Storm doses first patient with solid tumour drug candidate

Candidate is first molecule targeting an RNA methyltransferase enzyme to enter development - News - PharmaTimes ....

Jerry Mcmahon , Josefin Beate Holz , Beate Holz , Solid Tumour ,

STORM Therapeutics doses first patient with oral METTL3 targeting drug candidate in a solid tumor Phase 1 study

/PRNewswire/ STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modifying. ....

United Kingdom , Jerry Mcmahon , Josefin Beate Holz , Justin Moser , Therapeutics Ltd , Taiho Ventures , Clinical Investigator Of Honorhealth Research Institute , Merck Kga , Ip Group , Merck Kgaa , Fast Track Initiative , Cambridge Innovation Capital , University Of Tokyo Innovation Platform , Honorhealth Research Institute , Seroba Life Sciences , Beate Holz , Associate Clinical Investigator , Pfizer Ventures , Cambridge Innovation Capitali Limited , Tokyo Innovation , Storm Therapeutics ,